Global Wearable Injectors Market Outlook, 2019 to 2024 – A $5.6+ Billion Industry Opportunity by 2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Wearable Injectors Market – Forecasts from 2019 to 2024” report has been added to ResearchAndMarkets.com’s offering.

Global wearable injectors market is projected to grow at a CAGR of 21.2% during the forecast period, reaching a total market size of US$5.617 billion in 2024 from US$1.772 billion in 2018.

The growth of the market may be attributed to the increase in the incidence of cancer and diabetes and the adoption of advanced technological products. Favorable reimbursement scenario in developed countries pertaining to wearable injectors will also augment the growth of the market during the forecast period. However, preference and availability of alternative drug delivery modes might hamper the growth of the market during the given time frame.

Report Scope

This report is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, end-user, and geography.

The global wearable injectors market segmented based on type, application, end-user, and geography. By type, the market has been segmented into on-body and off-body. By application, the market has been segmented into cardiovascular diseases, diabetes, Parkinson’s disease, and others. By the end-user, the market has been segmented into hospitals and clinics and home care settings.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the Global Wearable Injectors market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the global wearable injectors market.

Key Topics Covered

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Currency

1.5. Assumptions

1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design

2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter’s Five Force Analysis

4.5.1 Bargaining Power of Suppliers

4.5.2 Bargaining Power of Buyers

4.5.3 Threat of New Entrants

4.5.4 Threat of Substitutes

4.5.5 Competitive Rivalry in the Industry

4.6. Life Cycle Analysis – Regional Snapshot

4.7. Market Attractiveness

5. GLOBAL WEARABLE INJECTORS MARKET BY TYPE

5.1. On-Body

5.2. Off-Body

6. GLOBAL WEARABLE INJECTORS MARKET BY APPLICATION

6.1. Cardiovascular Diseases

6.2. Diabetes

6.3. Parkinson’s Disease

6.4. Others

7. GLOBAL WEARABLE INJECTORS MARKET BY END USER

7.1. Hospitals and Clinics

7.2. Home Care Settings

8. GLOBAL WEARABLE INJECTORS MARKET BY GEOGRAPHY

8.1. North America

8.1.1. USA

8.1.2. Canada

8.1.3. Mexico

8.2. South America

8.2.1. Brazil

8.2.2. Argentina

8.2.3. Others

8.3. Europe

8.3.1. Germany

8.3.2. France

8.3.3. United Kingdom

8.3.4. Spain

8.3.5. Others

8.4. Middle East and Africa

8.4.1. Israel

8.4.2. Saudi Arabia

8.4.3. Others

8.5. Asia Pacific

8.5.1. China

8.5.2. Japan

8.5.3. South Korea

8.5.4. India

8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Competitive Benchmarking and Analysis

9.2. Recent Investment and Deals

9.3. Strategies of Key Players

10. COMPANY PROFILES

10.1. E3D Elcam Drug Delivery Devices

10.2. Subcuject ApS

10.3. BD

10.4. Enable Injections

10.5. Ypsomed AG

10.6. West Pharmaceutical Services

10.7. Unilife Corporation

10.8. Amgen

For more information about this report visit https://www.researchandmarkets.com/r/66h8l2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900